ConductScience.org, home

Paper194247

Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution.

Klein G and 1 other. Proc Natl Acad Sci U S A, 1977. Cited by 178 papers, by iCite.

Cite this record

ConductScience Library. Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution. Papers, record 194247. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/194247

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution.
PubMed
Journal
Proc Natl Acad Sci U S A
PubMed
Year
1977
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S., Review
PubMed
Citations, by iCite
178
iCite
Relative citation ratio, by iCite
3.84
iCite
Revised in PubMed
2020-12-12
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Klein GG
2Klein EE

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GenesMajor topic
NeoplasmsMajor topic
Tumor Virus InfectionsMajor topic
Animals
Antigens, Neoplasm
Antigens, Viral
Burkitt Lymphoma
Herpesvirus 4, Human
Humans
Immunity, Cellular
Mice
Mice, Inbred AKR
Oncogenic Viruses
T-Lymphocytes

Source PubMed

Download CSV of topics

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11055422Trisomy of chromosome 15 in spontaneous leukemia of AKR mice.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/1055422PubMed
21079330Killer T cells in a Burkitt's lymphoma biopsy.Nature1975https://conductscience.org/library/papers/1079330PubMed
31080480Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.Int J Cancer1975https://conductscience.org/library/papers/1080480PubMed
41082915Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems.J Exp Med1976https://conductscience.org/library/papers/1082915PubMed
51086218"Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell.Eur J Immunol1975https://conductscience.org/library/papers/1086218PubMed
61150347Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line.Int J Cancer1975https://conductscience.org/library/papers/1150347PubMed
71234049"Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype.Eur J Immunol1975https://conductscience.org/library/papers/1234049PubMed
81257779From the molecular biology of oncogenic DNA viruses to cancer.Science1976https://conductscience.org/library/papers/1257779PubMed
1113914573Histocompatibility genes of mice. III. H-1 and H-4, two histocompatibility loci in the first linkage group.Immunology1961https://conductscience.org/library/papers/13914573PubMed
12165518Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/165518PubMed
13173019Immunosurveillance of naturally occurring feline leukemia.Science1975https://conductscience.org/library/papers/173019PubMed
14174397Horizontally and vertically transmitted oncornaviruses of cats.Adv Cancer Res1975https://conductscience.org/library/papers/174397PubMed
15191377Vaccination against oncogenic herpesviruses - a review.IARC Sci Publ (1971)1975https://conductscience.org/library/papers/191377PubMed
16322458Chromosomal abnormalities and their specificity in human neoplasms: an assessment of recent observations by banding techniques.Adv Cancer Res1977https://conductscience.org/library/papers/322458PubMed
17322459Temperature-sensitive mutations in animal cells.Adv Cancer Res1977https://conductscience.org/library/papers/322459PubMed
184113130Marker band in one chromosome 14 from Burkitt lymphomas.Nature1972https://conductscience.org/library/papers/4113130PubMed
194131386Immunological aspects of chemical carcinogenesis.Adv Cancer Res1973https://conductscience.org/library/papers/4131386PubMed
204133586Antibody reactions to herpesvirus saimiri (HVS)-induced early and late antigens (EA and LA) in HVS-infected squirrel, marmoset and owl monkeys.Int J Cancer1973https://conductscience.org/library/papers/4133586PubMed
214326228Ciromosomal control of reversion in transformed cells.Nature1971https://conductscience.org/library/papers/4326228PubMed
224338345Tumor etiology and chromosome pattern.Science1972https://conductscience.org/library/papers/4338345PubMed

See all 36 referencesDownload CSV of references

Cited by49

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 178 citations.

PMIDTitleJournalYearIn PapersSource
40266514The Tumor Immune Environment: Advances in the Cancer Immunotherapy Era.Methods Mol Biol2025https://conductscience.org/library/papers/40266514PubMed
36476657Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy.Br J Cancer2023https://conductscience.org/library/papers/36476657PubMed
34937915The foundations of immune checkpoint blockade and the ipilimumab approval decennial.Nat Rev Drug Discov2022https://conductscience.org/library/papers/34937915PubMed
33455477In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology.Int J Hyperthermia2020https://conductscience.org/library/papers/33455477PubMed
29805573Elevated peripheral blood B lymphocytes and CD3+CD4-CD8- T lymphocytes in patients with non-small cell lung cancer: A preliminary study on peripheral immune profile.Oncol Lett2018https://conductscience.org/library/papers/29805573PubMed
28289211George Klein: 1925-2016.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28289211PubMed
26690220Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches.Cancers (Basel)2015https://conductscience.org/library/papers/26690220PubMed
26042126Dendritic cell-based vaccination in cancer: therapeutic implications emerging from murine models.Front Immunol2015https://conductscience.org/library/papers/26042126PubMed
24457417Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy.Nat Rev Cancer2014https://conductscience.org/library/papers/24457417PubMed
23454765Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance.J Clin Invest2013https://conductscience.org/library/papers/23454765PubMed
23202942A tumor surveillance model: a non-coding RNA senses neoplastic cells and its protein partner signals cell death.Int J Mol Sci2012https://conductscience.org/library/papers/23202942PubMed
22720237Tgf-β1 produced by activated CD4(+) T Cells Antagonizes T Cell Surveillance of Tumor Development.Oncoimmunology2012https://conductscience.org/library/papers/22720237PubMed
22378190The determinants of tumour immunogenicity.Nat Rev Cancer2012https://conductscience.org/library/papers/22378190PubMed
22248703T cell- but not tumor cell-produced TGF-β1 promotes the development of spontaneous mammary cancer.Oncotarget2011https://conductscience.org/library/papers/22248703PubMed
22212863Targeting stroma to treat cancers.Semin Cancer Biol2012https://conductscience.org/library/papers/22212863PubMed
21757379T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-β1 cytokine.Immunity2011https://conductscience.org/library/papers/21757379PubMed
21714479Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes.Cancer Immun2011https://conductscience.org/library/papers/21714479PubMed
20842057Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice.J Immunother2010https://conductscience.org/library/papers/20842057PubMed
17149595Immune reconstitution prevents metastatic recurrence of murine osteosarcoma.Cancer Immunol Immunother2007https://conductscience.org/library/papers/17149595PubMed
16873770Early manifestations of NNK-induced lung cancer: role of lung immunity in tumor susceptibility.Am J Respir Cell Mol Biol2007https://conductscience.org/library/papers/16873770PubMed

See all 49 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/194247

GET https://conductscience.org/api/papers/v1/194247/references?page=2